Decoy Therapeutics Inc.
DCOY· Nasdaq
DCOYDecoy Therapeutics Inc.
Filed Aug 3, 2016 · 10-Q · 34 days after period end · 0001615219-16-000218
| Metric | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|
| Revenue | $112.69K | $0.00 | — |
| Net Income | -$11.36M | -$7.08M | -$2.19M |
| EPS Diluted | -$0.71 | -$0.47 | -$1.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 3, 2016 · 34 d after period end
